Stockreport

Protalix BioTherapeutics to Announce Fiscal Year 2025 Financial Results and Business Update on March 18, 2026

Protalix BioTherapeutics, Inc. (DE)  (PLX) 
PDF Company to host conference call and webcast at 8:00 a.m. EDTCARMIEL, Israel, March 11, 2026 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopha [Read more]